ClinicalTrials.gg
Sign In

National Cancer Institute (NCI): Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

The registry lists 59 Leukemia, Myelogenous, Chronic, BCR-ABL Positive studies with National Cancer Institute (NCI) as lead sponsor. 1 are open to participants now and 9 have results posted.

Phase 1 43Phase 2 19No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

All Leukemia, Myelogenous, Chronic, BCR-ABL Positive studies →National Cancer Institute (NCI): all focus areas →